OpenURL Connection Search

Select item for more details and to access through your institution.

Treatment of inborn errors of immunity patients with inflammatory bowel disease phenotype by allogeneic stem cell transplantation.
Published in:
British Journal of Haematology, 2023, v. 200, n. 5, p. 595, doi. 10.1111/bjh.18497
By:
- Moser, Laura M.;
- Fekadu, Julia;
- Willasch, André;
- Rettinger, Eva;
- Sörensen, Jan;
- Jarisch, Andrea;
- Kirwil, Marta;
- Lieb, Adrian;
- Holzinger, Dirk;
- Calaminus, Gabriele;
- Bader, Peter;
- Bakhtiar, Shahrzad
Publication type:
Article
Bone Marrow Assessment in Liver Cirrhosis Patients with Otherwise Unexplained Peripheral Blood Cytopenia.
Published in:
Journal of Clinical Medicine, 2023, v. 12, n. 13, p. 4373, doi. 10.3390/jcm12134373
By:
- Koschade, Sebastian E.;
- Moser, Laura M.;
- Sokolovskiy, Artur;
- Michael, Florian A.;
- Serve, Hubert;
- Brandts, Christian H.;
- Finkelmeier, Fabian;
- Zeuzem, Stefan;
- Trebicka, Jonel;
- Ferstl, Philip;
- Ballo, Olivier
Publication type:
Article
Retargeting of NK-92 Cells against High-Risk Rhabdomyosarcomas by Means of an ERBB2 (HER2/Neu)-Specific Chimeric Antigen Receptor.
Published in:
Cancers, 2021, v. 13, n. 6, p. 1443, doi. 10.3390/cancers13061443
By:
- Gossel, Leonie D. H.;
- Heim, Catrin;
- Pfeffermann, Lisa-Marie;
- Moser, Laura M.;
- Bönig, Halvard B.;
- Klingebiel, Thomas E.;
- Bader, Peter;
- Wels, Winfried S.;
- Merker, Michael;
- Rettinger, Eva;
- Poupot, Mary
Publication type:
Article
ErbB2 (HER2)-CAR-NK-92 cells for enhanced immunotherapy of metastatic fusion-driven alveolar rhabdomyosarcoma.
Published in:
Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1228894
By:
- Heim, Catrin;
- Moser, Laura M.;
- Kreyenberg, Herman;
- Bonig, Halvard B.;
- Tonn, Torsten;
- Wels, Winfried S.;
- Gradhand, Elise;
- Ullrich, Evelyn;
- Meister, Michael T.;
- Koerkamp, Marian Groot;
- Holstege, Frank C. P.;
- Drost, Jarno;
- Klusmann, Jan-Henning;
- Bader, Peter;
- Merker, Michael;
- Rettinger, Eva
Publication type:
Article

Found: 4

Treatment of inborn errors of immunity patients with inflammatory bowel disease phenotype by allogeneic stem cell transplantation.

Bone Marrow Assessment in Liver Cirrhosis Patients with Otherwise Unexplained Peripheral Blood Cytopenia.

Retargeting of NK-92 Cells against High-Risk Rhabdomyosarcomas by Means of an ERBB2 (HER2/Neu)-Specific Chimeric Antigen Receptor.

ErbB2 (HER2)-CAR-NK-92 cells for enhanced immunotherapy of metastatic fusion-driven alveolar rhabdomyosarcoma.